Abstract:Eleven-nineteen leukemia (ENL) protein is a histone acetylation reader essential for disease maintenance in acute leukemias, in particular, the mixed-lineage leukemia (MLL)-rearranged leukemia. In this study, we carried out high-throughput screening of a small-molecule library to identify inhibitors for the ENL YEATS domain. Structure–activity relationship studies of the hits and structure-based inhibitor design led to two compounds, 11 and 24, with IC50 values below 100 nM in inhibiting the ENL–acetyl-H3 interaction. Both compounds, and their precursor compound 7, displayed strong selectivity toward the ENL YEATS domain over all other human YEATS domains. Moreover, 7 exhibited on-target inhibition of ENL in cultured cells and a synergistic effect with the bromodomain and extraterminal domain inhibitor JQ1 in killing leukemia cells. Together, we have developed selective chemical probes for the ENL YEATS domain, providing the basis for further medicinal chemistry-based optimization to advance both basic and translational research of ENL.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00367?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00367</a>.Overview of screen assay development, IC50 of top compounds, SPR and NMR data, cell growth inhibition, cell permeability assay, CETSA result of 7 in HeLa, qRT-PCR data, synergistic effect of 7 and JQ1 in MV4-11, molecular docking models of compounds bound to AF9 and ENL YEATS domains, HPLC traces for lead compounds, and table of the structure and IC50 of compounds from HTS with IC50 below 5 μM (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_002.csv">CSV</a>)Docking models (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00367/suppl_file/jm1c00367_si_003.zip">ZIP</a>)This article has not yet been cited by other publications.

Structure-guided development of YEATS domain inhibitors by targeting pi-pi-pi stacking.

Structure-guided Development of YEATS Domain Inhibitors by Targeting Π-Π-π Stacking

Selective Targeting of AF9 YEATS Domain by Cyclopeptide Inhibitors with Preorganized Conformation.

Discovering potential inhibitors of YEATS domain of YEATS2 through virtual screening, molecular optimization and molecular dynamics simulation

Structural insights into the π-π-π stacking mechanism and DNA-binding activity of the YEATS domain

Discovery of Selective Small-Molecule Inhibitors for the ENL YEATS Domain

Identification and Structure-Function Analyses of an Allosteric Inhibitor of the Tyrosine Phosphatase PTPN22.

Leveraging a Phage-Encoded Noncanonical Amino Acid: A Novel Pathway to Potent and Selective Epigenetic Reader Protein Inhibitors

Chemical Inhibition of ENL/AF9 YEATS Domains in Acute Leukemia

Fragment-Based Discovery of AF9 YEATS Domain Inhibitors

Phage-Assisted, Active Site-Directed Ligand Evolution with a Genetically Encoded Nε-Butyryl-L-Lysine to Identify a Cellularly Potent and Selective Inhibitor for the ENL YEATS Domain as an Anti-Leukemia Agent

Selective inhibition of BET bromodomains

Identification and Characterization of Benzo[d]oxazol-2(3H)-one Derivatives As the First Potent and Selective Small-Molecule Inhibitors of Chromodomain Protein CDYL

YEATS Domain—A Histone Acylation Reader in Health and Disease

Structure-Based Design and Characterization of the Highly Potent and Selective Covalent Inhibitors Targeting the Lysine Methyltransferases G9a/GLP

Structure-aided development of small molecule inhibitors of ENPP1, the extracellular phosphodiesterase of the immunotransmitter cGAMP

Structure-guided development of affinity probes for tyrosine kinases using chemical genetics

Lead Optimization of Small Molecule ENL YEATS Inhibitors to Enable In Vivo Studies: Discovery of TDI-11055

Small-molecule inhibition of the acyl-lysine reader ENL as a strategy against acute myeloid leukemia

Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors

Cyclic peptides target the aromatic cage of a PHD-finger reader domain to modulate epigenetic protein function